REPLIGEN CORP Operating Leases, Future Minimum Payments, Due in Five Years
REPLIGEN CORP (RGEN) had Operating Leases, Future Minimum Payments, Due in Five Years of $1.32 million as of 2018-12-31, per its 10-Q filed 2019-10-31.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears · last filed 2019-10-31
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $1.32M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $1.46M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $2.48M.
- 2016-09-30: Operating Leases, Future Minimum Payments, Due in Five Years $2.41M.
| Period end | Operating Leases, Future Minimum Payments, Due in Five Years |
|---|---|
| 2018-12-31 | $1.32M 10-Q · filed 2019-10-31 |
| 2017-12-31 | $1.46M 10-K · filed 2018-02-22 |
| 2016-12-31 | $2.48M 10-K · filed 2017-02-23 |
| 2016-09-30 | $2.41M 10-Q · filed 2016-11-03 |
| 2015-12-31 | $1.37M 10-K · filed 2016-02-25 |
| 2014-12-31 | $1.42M 10-K · filed 2015-03-17 |
| 2013-12-31 | $1.09M 10-K · filed 2014-03-14 |
| 2012-12-31 | $1.66M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |